Skip to main content

Nasdaq FB FaceBook

Starpharma's VivaGel Approval Denied By FDA

2 years 7 months ago
(RTTNews) - Australian pharma company Starpharma Holdings Ltd. (SPL.AX) Monday announced that the US Food and Drug Administration or FDA did not approve VivaGel, a treatment for Bacterial vaginosis (BV), and sought additional clinical efficacy data.
RTTNews
Checked
14 minutes 27 seconds ago
This feed is responsible for generating the rss feed related to the topic META
Subscribe to Nasdaq FB FaceBook feed